TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Nektar Therapeutics (NASDAQ: NKTR) Investor Securities Class Action Lawsuit 10/30/2018

  • If you purchased shares of Nektar Therapeutics (NASDAQ: NKTR), you have certain options. Please contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Lawsuit Overview

December 30, 2020 - The court granted the defendants' motion to dismiss. The plaintiffs were not given leave to amend the complaint. September 17, 2020 - A motion to dismiss the second consolidated complaint was filed. August 10, 2020 - A second consolidated complaint was filed. July 13, 2020 - The court granted the defendants' motion to dismiss. The plaintiffs were given leave to...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: